To mitigate potential bias and ensure comprehensive coverage of tumor types potentially associated with DDR1 upregulation, we compiled the union of cancer types identified as DDR1-high across the three databases for downstream analyses, including survival and immune correlation studies. This evidence concerns the gene DDR1 and neoplasm.